TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL

Go back to TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
TG THERAP (NASDAQ: TGTX) Delayed: 57.16 --0 (-0%)
Previous Close $57.16    52 Week High $14.87 
Open $57.16    52 Week Low $4.90 
Day High $57.16    P/E N/A 
Day Low $57.16    EPS $-0.67 
Volume 276